Perinatal HIV Transmission
Hours: 1.00
HIV transmission can occur during pregnancy, at birth, or through breastfeeding. HIV screening recommendations for pregnant women and the management of those found HIV infected have evolved since being introduced in the late 1990s and the risk of perinatal HIV transmission has significantly decreased (Shihan et al., 2019). The most effective way to avert perinatal HIV infection is to prevent initial infection in women by encouraging preconception and prenatal HIV counseling, testing, and treatment. In women with known HIV infection, preconception counseling regarding perinatal transmission, appropriate antiretroviral treatment, and continued monitoring of HIV viral load is recommended to prevent perinatal transmission (The Panel, 2021). The goal of this continuing education module is to help nurses advance their understanding of perinatal HIV transmission, prevention factors, and related legal and ethical issues.
HIV transmission can occur during pregnancy, at birth, or through breastfeeding. HIV screening recommendations for pregnant women and the management of those found HIV infected have evolved since being introduced in the late 1990s and the risk of perinatal HIV transmission has significantly decreased (Shihan et al., 2019). The most effective way to avert perinatal HIV infection is to prevent initial infection in women by encouraging preconception and prenatal HIV counseling, testing, and treatment. In women with known HIV infection, preconception counseling regarding perinatal transmission, appropriate antiretroviral treatment, and continued monitoring of HIV viral load is recommended to prevent perinatal transmission (The Panel, 2021). The goal of this continuing education module is to help nurses advance their understanding of perinatal HIV transmission, prevention factors, and related legal and ethical issues.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.00 Nursing Contact Hours after successfully completing this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Identify factors that increase the risk of perinatal HIV transmission.
Discuss strategies to reduce mother-to-infant HIV transmission.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: HIV Transmission During Pregnancy
Meet Ellen
Epidemiology of Mother to Child Transmission of HIV
Testing Strategy for Prevention of Perinatal HIV Transmission
HIV Counseling and Testing
Transmission of HIV in Pregnancy
Summary
Section 3: Treatment as Prevention of Perinatal HIV Transmission
Current Treatment and Management Guidelines
Medication Therapies
Assessment and Monitoring
Modified Obstetric Procedures
ARV Pregnancy Registry and Resources
Legal Issues
Ethical Issues
Ellen’s Outcomes
Summary
Section 4: Clinical Vignette
Meet Mary
Section 5: Conclusion
Course Summary
Course Contributors
Resources
References
Christine A. Balt, DNP, FNP-BC, AACRN is a nurse practitioner in the Eskenazi Health Infectious Disease Clinic in Indianapolis, Indiana. She is the Lead Advanced Practice Provider for the Eskenazi Health System and Eskenazi Medical Group. Dr. Balt is also the clinical coordinator for the Midwest AIDS Training and Education Center, (Indiana site). Disclosure: Christine Ann Balt, DNP, FNP-BC, AACRN has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.Staff Writer: Kimberly Workman, MA
Ms. Workman is an Instructional Designer at Relias. She has a Master of Arts in Technology and Communication, as well as graduate certificates in Public Health, Epidemiology, and Digital Communications. Ms. Workman has a background in writing and designing online continuing medical education for physicians and other health professionals on multiple educational platforms, including web-based, game-based, and immersive learning environments. She has also used simulation training extensively to connect learning to real-world environments. Disclosure: Kimberly Workman, MA discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
The target audience for this course is: Nurses; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
